Literature DB >> 12613193

TGF-beta signaling alterations in cancer.

Yansong Bian1, Virginia Kaklamani, Jennifer Reich, Boris Pasche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12613193     DOI： 10.1007/0-306-48158-8_3

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  4 in total

1.  TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.

Authors:  Ru-Yan Liao; Chen Mao; Li-Xin Qiu; Hong Ding; Qing Chen; Hai-Feng Pan
Journal:  Mol Biol Rep       Date:  2009-11-01       Impact factor: 2.316

2.  TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancer.

Authors:  Ana Martinez-Canto; Adela Castillejo; Trinidad Mata-Balaguer; Maria-Isabel Castillejo; Eva Hernandez-Illan; Esperanza Irles; Victor Manuel Barbera; Cecilia Egoavil; Carla Guarinos; Cristina Alenda; Enrique Ochoa; Rafael Lazaro; Silvia Fajardo; Javier Lacueva; Rafael Calpena; Jose Luis Soto
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

3.  The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study.

Authors:  Adela Castillejo; Trinidad Mata-Balaguer; Carla Guarinos; María-Isabel Castillejo; Ana Martínez-Cantó; Víctor-Manuel Barberá; Paola Montenegro; Enrique Ochoa; Rafael Lázaro; Carmen Guillén-Ponce; Alfredo Carrato; José-Luís Soto
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

4.  No major association between TGFBR1*6A and prostate cancer.

Authors:  Virginia Kaklamani; Lisa Baddi; Diana Rosman; Junjian Liu; Nathan Ellis; Carole Oddoux; Harry Ostrer; Yu Chen; Habibul Ahsan; Kenneth Offit; Boris Pasche
Journal:  BMC Genet       Date:  2004-09-22       Impact factor: 2.797
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.